AI drug discovery giant Isomorphic Labs raises €4.5 billion in blockbuster funding round
Isomorphic Labs, an AI company focussed on designing and developing new medicines, today announced a €4.5 billion ($5 billion) Series C financing round to accelerate the scientific breakthroughs and proprietary AI advances. The round was co-led by Greenoaks and Sequoia Capital, alongside Andreessen

<p>Isomorphic Labs, an AI company focussed on designing and developing new medicines, today announced a €4.5 billion ($5 billion) Series C financing round to accelerate the scientific breakthroughs and proprietary AI advances. The round was co-led by Greenoaks and Sequoia Capital, alongside Andreessen </p>